Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – X-ray contrast imaging agent
Patent
1995-03-09
1995-12-05
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
X-ray contrast imaging agent
560 41, 562449, 562887, A61K 4904, C07C27102
Patent
active
054726832
ABSTRACT:
This invention relates to methods of x-ray diagnostic imaging the blood pool, liver, spleen, and/or lymph system of a mammal comprising administering a contrast effective amount of a mixed carbamic anhydride as a contrast agent having the structure ##STR1## X is H, NR.sup.1 R.sup.2 or CONR.sup.1 R.sup.3, R.sup.1 is H or alkyl
REFERENCES:
patent: 3097228 (1963-07-01), Larsen
Eastman Kodak Company
Hollinden Gary E.
Rand Scott C.
Rosenstein Arthur H.
LandOfFree
Nanoparticulate diagnostic mixed carbamic anhydrides as X-ray co does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nanoparticulate diagnostic mixed carbamic anhydrides as X-ray co, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nanoparticulate diagnostic mixed carbamic anhydrides as X-ray co will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1372242